Quick Answer
BIODESIX INC reported Diluted EPS of $4.67 per share (loss) for fiscal year 2025.
BIODESIX INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$4.67 | +29.7% |
| 2024 | -$6.64 | -937.5% |
| 2023 | -$0.64 | +58.7% |
| 2022 | -$1.55 | +1.9% |
| 2021 | -$1.58 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.16 | +17.1% | -1350.0% |
| June 30, 2025 | -$0.08 | +0.0% | +0.0% |
| March 31, 2025 | -$0.08 | +42.9% | +94.3% |
| September 30, 2024 | -$1.40 | -900.0% | -1650.0% |
| June 30, 2024 | -$0.08 | +52.9% | +42.9% |
| March 31, 2024 | -$0.14 | +41.7% | +0.0% |
| September 30, 2023 | -$0.14 | +58.8% | +17.6% |
| June 30, 2023 | -$0.17 | +57.5% | +29.2% |
- BIODESIX INC showed an increase of +29.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, BIODESIX INC’s diluted eps has declined by 195.6% (from $1.58 per share (loss) to $4.67 per share (loss)).
- The most recent figure is from BIODESIX INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: